Verge Genomics

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE platform, featuring one of the fields largest and most comprehensive databases of multi-omic patient data. The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinsons disease. Verge actively seeks a diverse applicant pool in...

Bioinformatics,genomics,drug discovery,neuroscience,als,and ftd

Verge genomics operates in the Biotechnology research industry.

Verge genomics's revenue is 11m - 100m

Verge genomics has 51 - 200 employees.